DuPont acquires Spectrum Plastics Group for $1.75 billion
DuPont announced on May 4 that it has acquired Spectrum Plastics Group for US$1.75 billion. The transaction is expected to close by the end of the third quarter of 2023.
Spectrum provides materials and technologies for specialty medical devices and components, including extruded medical catheters, catheter technology, medical balloons, flexible packaging and films. Rapidly growing key therapeutic areas such as structural heart disease, electrophysiology, surgical robotics and cardiovascular are Spectrum's strategic focus. The company currently has more than 2,200 employees.
DuPont believes the deal will strengthen its position in the fast-growing, less cyclical healthcare market. Following the acquisition, approximately 10 percent of DuPont's combined revenues will come from the healthcare business.
2026-08-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Another Strategic Move! DuPont Launches a New Specialty Lubricants Project in Zhangjiagang
-
DuPont Bids Farewell to Its Aramid Business with a $1.8 Billion Sale
-
DuPont Launches Silver Nanowire Products in Korea
-
DuPont Plans to Divest the Electronics Business on November 1, 2025
-
DuPont and Zhen Ding Technology join hands to promote the development of high-end printed circuit board technology
-
Deltech Takes Over Divinylbenzene Production from DuPont
-
DuPont Acquires Donatelle Plastics
-
DuPont to split into three companies, CEO Brin resigns
-
DuPont launches Tyvek TrifectaA2 fire-resistant breathable membrane
-
Joined Forces! DuPont and Nippon Paint Jointly Launch PVF Coating Solutions
Recommend Reading
-
Symrise Opens New Production Unit in Granada to Ensure Safer Supply of Bio-Based Pentylene Glycol
-
BASF and Nihon Nohyaku Partner for Fruit Crop Protection in Japan
-
NHU and Sinopec Advance Liquid Methionine Project
-
From LANXESS’s 50% to Tire Makers’ 5%: The Rubber Industry Chain Is Experiencing a “Decreasing-Cost Transmission”
-
Lilly Bets US$3 Billion on China While Simultaneously Cracking Down on the Gray Market for Weight-Loss Drugs
-
March 12 International Crude Oil Opens with a Sharp Rise in Asian Trading Session
-
Cost and Supply Resonance Drives Up Prices—Melamine Market Rises Strongly
-
Soaring and Then Plunging Rapidly! The Roller-Coaster Ride of Phenol Comes to an End—What’s Next for the Market?
-
On March 11, the pure benzene market in China continued to see a significant decrease
-
Demand Falls Short of Expectations, Polyethylene Weakly Operates